Max Robotics — Global Service Robot Directory + US Certification

About

Waldemar Uhl is a leading figure in pancreatic surgery, with a career dedicated to improving outcomes for patients with pancreatic diseases. His research focuses on the surgical management of pancreatic cancer and pancreatitis, with a particular emphasis on advancing minimally invasive techniques. Uhl has been instrumental in evaluating the global adoption and outcomes of minimally invasive pancreatoduodenectomy (MIPD), a complex procedure for pancreatic head tumors. His landmark international multi-registry analysis, published in 2024, revealed significant transatlantic differences in the use and outcomes of MIPD compared to open surgery, highlighting critical variations in surgical practice and patient selection across countries. This work, already garnering attention with early citations, underscores his commitment to evidence-based surgical innovation. Beyond this, Uhl’s broader contributions include pioneering studies on pancreatic enzyme replacement therapy and surgical techniques for chronic pancreatitis. With a career spanning decades and a citation record reflecting his influence, he remains a key voice in shaping the future of pancreatic surgery, advocating for rigorous data-driven approaches to improve patient care worldwide.